ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines–an EAACI‐ARIA position paper
Further to the approval of the Coronavirus disease 2019 (COVID‐19) vaccine BNT162b2,
several severe anaphylaxis cases occured within the first few days of public vaccination. An …
several severe anaphylaxis cases occured within the first few days of public vaccination. An …
[HTML][HTML] Severe allergic reactions to the COVID-19 vaccine–statement and practical consequences
J Kleine-Tebbe, L Klimek, E Hamelmann… - Allergologie …, 2021 - ncbi.nlm.nih.gov
On December 10, 2020, the BBC reported two allergic adverse events following the first
injection of the BioNTech COVID-19 vaccine BNT162b2. Up to December 19, 2020, severe …
injection of the BioNTech COVID-19 vaccine BNT162b2. Up to December 19, 2020, severe …
Allergy to COVID-19 vaccines: a current update
B Cabanillas, N Novak - Allergology International, 2021 - jstage.jst.go.jp
abstract Adverse allergic reactions due to the administration of the vaccines developed for
the protection of coronavirus disease 2019 (COVID-19) have been reported since the …
the protection of coronavirus disease 2019 (COVID-19) have been reported since the …
[HTML][HTML] Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI
L Klimek, KC Bergmann, R Brehler, W Pfützner… - Allergo journal …, 2021 - Springer
Background For the preventive treatment of the 2019 coronavirus disease (COVID-19) an
unprecedented global research effort studied the safety and efficacy of new vaccine …
unprecedented global research effort studied the safety and efficacy of new vaccine …
[HTML][HTML] COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee
PJ Turner, IJ Ansotegui, DE Campbell… - World Allergy …, 2021 - Elsevier
Vaccines against COVID-19 (and its emerging variants) are an essential global intervention
to control the current pandemic situation. Vaccines often cause adverse events; however …
to control the current pandemic situation. Vaccines often cause adverse events; however …
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
The first approved COVID‐19 vaccines include Pfizer/BioNTech BNT162B2, Moderna
mRNA‐1273 and AstraZeneca recombinant adenoviral ChAdOx1‐S. Soon after approval …
mRNA‐1273 and AstraZeneca recombinant adenoviral ChAdOx1‐S. Soon after approval …
Allergies and COVID‐19 vaccines: an ENDA/EAACI position paper
Background Anaphylaxis, which is rare, has been reported after COVID‐19 vaccination, but
its management is not standardized. Method Members of the European Network for Drug …
its management is not standardized. Method Members of the European Network for Drug …
[HTML][HTML] Allergic reactions to COVID-19 vaccines: risk factors, frequency, mechanisms and management
N Luxi, A Giovanazzi, A Arcolaci, P Bonadonna… - BioDrugs, 2022 - Springer
Conventional vaccines have been widely studied, along with their risk of causing allergic
reactions. These generally consist of mild local reactions and only rarely severe …
reactions. These generally consist of mild local reactions and only rarely severe …
[HTML][HTML] Maintaining safety with SARS-CoV-2 vaccines
MC Castells, EJ Phillips - New England Journal of Medicine, 2021 - Mass Medical Soc
Allergic Reactions to Covid-19 Vaccine The vast majority of people who have received the
Covid-19 vaccine to date have had self-limited local or low-grade systemic reactions that …
Covid-19 vaccine to date have had self-limited local or low-grade systemic reactions that …
[HTML][HTML] Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: position statement of the German allergy …
L Klimek, N Novak, E Hamelmann, T Werfel… - Allergo journal …, 2021 - Springer
Two employees of the National Health Service (NHS) in England developed severe allergic
reactions following administration of BNT162b2 vaccine against COVID-19 (coronavirus …
reactions following administration of BNT162b2 vaccine against COVID-19 (coronavirus …